|
|
|||
| |||||||||||||||||||||||||||||||
Since 1962, when Congress required proof of the efficacy and safety of drugs approved by the Food and Drug Administration (FDA), the FDA's summary opinions have been fairly consistent with those of the medical profession, as outlined in pharmacology textbooks. When the FDA arouses public wrath, it is often for moving more slowly than its European counterparts. Yet, according to John Abraham, a sociologist at the University of Reading in England, the story is not so simple. His book about testing drugs for efficacy and safety in the United States and the United Kingdom is illustrated by case histories and
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |